Role of site-selective cAMP analogs in the control and reversal of malignancy.
Two isoforms of cAMP receptor protein, RI and RII, the regulatory subunits of cAMP-dependent protein kinase, transduce opposite signals, the RI being stimulatory and the RII being inhibitory of cell proliferation. In normal cells RI and RII exist at a specific physiological ratio whereas in cancer cells such physiological balance of these receptor proteins is disrupted. Reversal and suppression of malignancy can be achieved when the physiologic ratio of these intracellular signal transducers of cAMP is restored as shown by the use of site-selective cAMP analogs, antisense oligodeoxynucleotides or gene transfer, suggesting new approaches to cancer control.
Cho-Chung
Y S
YS
Cellular Biochemistry Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Clair
T
T
Tortora
G
G
Yokozaki
H
H
D000818:Animals; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line / Q000187:drug effects; D000242:Cyclic AMP / Q000031:analogs & derivatives* / Q000502:physiology; D006801:Humans; D007527:Isoenzymes / Q000378:metabolism / Q000502:physiology*; D009369:Neoplasms / Q000201:enzymology* / Q000378:metabolism / Q000473:pathology; D011494:Protein Kinases / Q000378:metabolism / Q000502:physiology*; D011953:Receptors, Cyclic AMP / Q000502:physiology*; D014407:Tumor Cells, Cultured / Q000187:drug effects
D007527:Isoenzymes; D011953:Receptors, Cyclic AMP; D000242:Cyclic AMP; D011494:Protein Kinases